Literature DB >> 21276306

Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.

N M Al-Mutairi1, S Ahmad, E Mokaddas.   

Abstract

SETTING: National Tuberculosis Reference Laboratory, Kuwait.
OBJECTIVE: To compare Genotype MTBDRplus (gMTBDR(+)), INNO-LiPA Rif.TB (INNO-LiPA), polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing for detecting rifampicin (RMP) and/or isoniazid (INH) resistance-associated mutations in the rpoB hot-spot region (HSR-rpoB), the katG codon 315 (katG315) and the inhA regulatory region (inhA-RR) among multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates.
DESIGN: A total of 82 MDR-TB and 43 pansusceptible M.tuberculosis BACTEC 460-characterised isolates were processed using molecular techniques and the Mycobacterial Growth Indicator Tube (MGIT) 960 system.
RESULTS: All susceptible strains contained wild-type sequences in target genes. RMP resistance was detected in respectively 78, 77 and 79 MDR-TB strains by gMTBDR(+), INNO-LiPA and HSR-rpoB sequencing. Two isolates with Ins514TTC mutation were detected as RMP-resistant by gMTBDR(+) but as RMP-susceptible by INNO-LiPA. One isolate with L533P mutation, detected as RMP-susceptible by gMTBDR(+), was detected as RMP-resistant by INNO-LiPA. Two of three isolates detected as RMP-susceptible by gMTBDR(+), INNO-LiPA, HSR-rpoB sequencing and the MGIT 960 system contained a I572F mutation that is outside HSR-rpoB. INH resistance was detected in respectively 76, 60, 60 and 22 MDR-TB strains by gMTBDR(+), katG315 PCR-RFLP, katG315 sequencing and inhA-RR sequencing.
CONCLUSIONS: Although gMTBDR(+) accurately detected ∼ 88% of MDR-TB strains, some rpoB mutations were either missed or were outside the region of analysis of the gMTBDR(+) assay.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21276306

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  21 in total

1.  Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.

Authors:  B Molina-Moya; G Kazdaglis; A Lacoma; C Prat; A Gómez; R Villar-Hernández; E García-García; L Haba; J Maldonado; S Samper; J Ruiz-Manzano; J Domínguez
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

2.  Rifampin drug resistance tests for tuberculosis: challenging the gold standard.

Authors:  Armand Van Deun; Kya J M Aung; Valentin Bola; Rossin Lebeke; Mohamed Anwar Hossain; Willem Bram de Rijk; Leen Rigouts; Aysel Gumusboga; Gabriela Torrea; Bouke C de Jong
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

3.  Discordance between Xpert MTB/RIF assay and Bactec MGIT 960 Culture System for detection of rifampin-resistant Mycobacterium tuberculosis isolates in a country with a low tuberculosis (TB) incidence.

Authors:  Eiman Mokaddas; Suhail Ahmad; Hanaa S Eldeen; Noura Al-Mutairi
Journal:  J Clin Microbiol       Date:  2015-01-21       Impact factor: 5.948

4.  Diversity of Nontuberculous Mycobacteria in Kuwait: Rapid Identification and Differentiation of Mycobacterium Species by Multiplex PCR, INNO-LiPA Mycobacteria v2 Assay and PCR Sequencing of rDNA.

Authors:  Suhail Ahmad; Eiman Mokaddas
Journal:  Med Princ Pract       Date:  2019-02-14       Impact factor: 1.927

5.  First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.

Authors:  Noura M Al-Mutairi; Suhail Ahmad; Eiman Mokaddas; Sahal Al-Hajoj
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

6.  Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.

Authors:  Pooja Singh; Amita Jain; Pratima Dixit; Shantanu Prakash; Indu Jaiswal; Vimala Venkatesh; Mastan Singh
Journal:  J Antibiot (Tokyo)       Date:  2014-07-23       Impact factor: 2.649

7.  Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations.

Authors:  Leen Rigouts; Mourad Gumusboga; Willem Bram de Rijk; Elie Nduwamahoro; Cécile Uwizeye; Bouke de Jong; Armand Van Deun
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

8.  Performance Comparison of GeneXpert MTB/RIF and ProbeTec ET Tests for Rapid Molecular Diagnosis of Extrapulmonary Tuberculosis in a Low TB/MDR-TB Incidence Country.

Authors:  Eiman Mokaddas; Suhail Ahmad; Hanaa Eldeen
Journal:  Med Princ Pract       Date:  2021-02-16       Impact factor: 1.927

9.  Variations in the occurrence of specific rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in Kuwait.

Authors:  Suhail Ahmad; Noura M Al-Mutairi; Eiman Mokaddas
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

10.  First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.

Authors:  Noura M Al-Mutairi; Suhail Ahmad; Eiman Mokaddas
Journal:  BMC Res Notes       Date:  2011-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.